Telehealth GLP-1 Prescriptions Lack Clinical Oversight

A new secret-shopper study in JAMA found that 90% of telehealth GLP-1 providers didn't follow clinical guidelines, often prescribing without required blood tests or relevant medical history. Yale researchers went undercover with 10 companies, highlighting a quick, easy, but potentially unsafe path to GLP-1 access.